- Home
- LASE vs VOR Comparison
LASE vs VOR Comparison
Compare LASE & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LASE
- VOR
- Stock Information
- Founded
- LASE 2019
- VOR 2015
- Country
- LASE United States
- VOR United States
- Employees
- LASE N/A
- VOR N/A
- Industry
- LASE Industrial Machinery/Components
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- LASE Industrials
- VOR Health Care
- Exchange
- LASE Nasdaq
- VOR Nasdaq
- Market Cap
- LASE 27.1M
- VOR 22.1M
- IPO Year
- LASE 2022
- VOR 2021
- Fundamental
- Price
- LASE $2.65
- VOR $1.43
- Analyst Decision
- LASE
- VOR Buy
- Analyst Count
- LASE 0
- VOR 7
- Target Price
- LASE N/A
- VOR $3.77
- AVG Volume (30 Days)
- LASE 127.3K
- VOR 38.3M
- Earning Date
- LASE 08-28-2025
- VOR 08-07-2025
- Dividend Yield
- LASE N/A
- VOR N/A
- EPS Growth
- LASE N/A
- VOR N/A
- EPS
- LASE N/A
- VOR N/A
- Revenue
- LASE $3,415,196.00
- VOR N/A
- Revenue This Year
- LASE N/A
- VOR N/A
- Revenue Next Year
- LASE N/A
- VOR N/A
- P/E Ratio
- LASE N/A
- VOR N/A
- Revenue Growth
- LASE N/A
- VOR N/A
- 52 Week Low
- LASE $1.58
- VOR $0.13
- 52 Week High
- LASE $19.80
- VOR $2.03
- Technical
- Relative Strength Index (RSI)
- LASE 57.27
- VOR 94.68
- Support Level
- LASE $1.84
- VOR $0.29
- Resistance Level
- LASE $2.76
- VOR $1.26
- Average True Range (ATR)
- LASE 0.21
- VOR 0.20
- MACD
- LASE 0.08
- VOR 0.18
- Stochastic Oscillator
- LASE 83.35
- VOR 99.96
About LASE Laser Photonics Corporation
Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, primarily laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.